文献速递造血干细胞移植与细胞治疗

凝血酶受体激活肽-6通过激活GPR15减轻急性移植物抗宿主病

Thrombin receptor activating peptide-6 decreases acute graft-versus-host disease through activating GPR15.
PubMed 文献 · Leukemia · 2024-03-08

G蛋白偶联受体15(GPR15)表达于T细胞,本研究鉴定凝血酶受体激活肽-6(TRAP-6,序列SFLLRN)为GPR15激活剂。在小鼠同种移植模型中,TRAP-6依赖供者T细胞GPR15表达减轻急性移植物抗宿主病,且不抑制抗A20淋巴瘤的移植物抗肿瘤疗效;突变体SALLRN保留抗急性GVHD作用并避免TRAP-6的不良反应。

要点

  • TRAP-6激活T细胞GPR15,抑制混合淋巴细胞反应需GPR15和β-arrestin2参与。
  • TRAP-6减轻小鼠急性GVHD依赖供者T细胞GPR15表达,且不影响抗A20淋巴瘤的GVT疗效。
  • 突变体SALLRN保留抗急性GVHD作用并避免TRAP-6的不良反应。

核心结论

  • TRAP-6激活T细胞上的GPR15,在小鼠中减轻急性GVHD且不损害GVT疗效。

研究设计与样本

  • 研究为小鼠同种移植模型及人血单个核细胞诱导的同种/异种反应实验,具体样本量原文未报告。

主要发现

  • TRAP-6介导的混合淋巴细胞反应抑制需要GPR15和β-arrestin2。
  • TRAP-6减轻小鼠同种移植模型急性GVHD,该效应依赖供者T细胞GPR15表达。
  • RNA-seq和蛋白分析显示TRAP-6增加β-arrestin2/TAB1结合并抑制TAK1和NF-κB-P65磷酸化。
  • TRAP-6抑制CD4+ T细胞中NF-κB-P65磷酸化,但增加CD8+ T细胞颗粒酶B表达。
  • TRAP-6减轻急性GVHD且不抑制针对A20淋巴瘤细胞的GVT疗效;SALLRN保留抗急性GVHD效应并避免TRAP-6的不良反应。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

G-protein coupled receptor 15 (GPR15) is expressed on T-cells. We previously reported knockout of GPR15 increased acute graft-versus-host disease (GvHD) in mice. In this study, we identified thrombin receptor activating peptide-6 (TRAP-6, peptide sequence: SFLLRN) as an activator of GPR15. GRP15 and β-arrestin2 were needed for TRAP-6-mediated inhibition of mixed lymphocyte reactions. TRAP-6 decreased acute GvHD in allotransplant models in mice, an effect dependent on GPR15-expression in donor T-cells. RNA-seq and protein analyses indicated TRAP-6 increased binding of β-arrestin2/TAB1 and inhibited phosphorylation of TAK1 and NF-κB-P65. GPR15 is expressed differently on CD4+ T-cells and CD8+ T-cells. TRAP-6 inhibited phosphorylation of NF-κB-P65 in CD4+ T-cells but increased granzyme B expression in CD8+ T-cells. TRAP-6 decreased acute GvHD without inhibiting graft-versus-tumor (GvT) efficacy against A20 lymphoma cells. SALLRN, a mutant of TRAP-6, preserved the anti-acute GvHD effect but avoided the adverse effects of TRAP-6. TRAP-6 and SALLRN also decreased allogeneic and xenogeneic reactions induced by human blood mononuclear cells. In conclusion, TRAP-6 activated GPR15 on T-cells and decreased acute GvHD in mice without impairing GvT efficacy.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Liu C, Lan Q, Cao S, et al. Thrombin receptor activating peptide-6 decreases acute graft-versus-host disease through activating GPR15. Leukemia. 2024. PMID: 38459169. doi:10.1038/s41375-024-02212-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。